三元生物
(301206)
| 流通市值：35.67亿 | | | 总市值：55.40亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 476,077,165.85 | 317,965,979 | 150,204,941.37 | 712,904,207.78 |
| 营业收入 | 476,077,165.85 | 317,965,979 | 150,204,941.37 | 712,904,207.78 |
| 二、营业总成本 | 450,764,643.46 | 288,093,382.43 | 140,915,661.83 | 694,776,643.89 |
| 营业成本 | 399,176,492.76 | 256,915,517.33 | 123,708,148.18 | 633,728,502.33 |
| 税金及附加 | 2,799,751.11 | 1,721,037.59 | 817,618.09 | 3,126,317.86 |
| 销售费用 | 6,176,169.39 | 4,267,456.32 | 1,683,681.72 | 6,967,383.73 |
| 管理费用 | 23,135,356.52 | 15,294,309.4 | 7,186,420.27 | 19,747,314.16 |
| 研发费用 | 24,800,042.4 | 14,794,149.7 | 9,744,135.17 | 41,232,951.56 |
| 财务费用 | -5,323,168.72 | -4,899,087.91 | -2,224,341.6 | -10,025,825.75 |
| 其中:利息收入 | 5,514,743.71 | 3,821,935.81 | 1,886,105.67 | 2,828,961.81 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 51,329,576.12 | 36,233,619.1 | 19,052,784.16 | 108,578,694.29 |
| 资产处置收益 | 10,577.18 | -36,368.8 | 1,131.16 | - |
| 信用减值损失(新) | 72,740.76 | -164,372.92 | -849,758.22 | -642,040.27 |
| 其他收益 | 1,057,160.99 | 663,002.99 | 396,202.98 | 1,880,037.69 |
| 四、营业利润 | 77,782,577.44 | 66,568,476.94 | 27,889,639.62 | 127,944,255.6 |
| 加:营业外收入 | 80,912.69 | 79,271.34 | 21,122.47 | 426,678.1 |
| 减:营业外支出 | 94,333.49 | 32,748.86 | - | 166,576.07 |
| 五、利润总额 | 77,769,156.64 | 66,614,999.42 | 27,910,762.09 | 128,204,357.63 |
| 减:所得税费用 | 10,484,491.79 | 9,247,149.57 | 3,019,073.41 | 23,253,017.46 |
| 六、净利润 | 67,284,664.85 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 67,284,664.85 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 67,398,745.48 | 57,481,930.48 | 24,913,986.7 | 104,951,340.17 |
| 少数股东损益 | -114,080.63 | -114,080.63 | -22,298.02 | - |
| 扣除非经常损益后的净利润 | 57,134,312.53 | 48,756,638.97 | 20,904,157.75 | 102,481,790.83 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.34 | 0.29 | 0.12 | 0.52 |
| (二)稀释每股收益 | 0.34 | 0.29 | 0.12 | 0.52 |
| 九、综合收益总额 | 67,284,664.85 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 |
| 归属于母公司股东的综合收益总额 | 67,398,745.48 | 57,481,930.48 | 24,913,986.7 | 104,951,340.17 |
| 归属于少数股东的综合收益总额 | -114,080.63 | -114,080.63 | -22,298.02 | - |
| 公告日期 | 2025-10-27 | 2025-08-29 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |